Response to Commentary on Azathioprine in Graves' Disease
Author Information
Author(s): Allam Magdy Mohamed, Ghazy Ramy Mohamed, Elzawawy Hanaa Tarek Hussein
Primary Institution: Alexandria University Student Hospital
Hypothesis
Does azathioprine improve remission rates in patients with severe Graves' disease?
Conclusion
Azathioprine significantly improves remission rates and reduces relapse in patients with severe Graves' disease.
Supporting Evidence
- Azathioprine improved remission rates from 33.4% to 87.5%.
- The study included 270 patients with severe Graves' disease.
- Participants were monitored for 12 months after stopping medication.
Takeaway
This study shows that a medicine called azathioprine can help people with a serious thyroid problem feel better and stay better for longer.
Methodology
Participants were randomly allocated into three groups receiving different doses of azathioprine along with conventional therapy.
Potential Biases
The open-label design could introduce potential bias.
Limitations
The study's open-label design and relatively small sample size may limit the generalizability of the results.
Participant Demographics
Participants were aged 30-65 years, with a gender distribution of 60% female in the azathioprine group.
Statistical Information
P-Value
0.002
Statistical Significance
p = 0.002
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website